The Authority organised an expert discussion in April 2019, to discuss certain elements related to the human health risk assessment. Due to concerns about genotoxicity and developmental neurotoxicity raised during that discussion, on 1 July 2019 the Commission sent a mandate to the Authority requesting a statement on the available outcomes of the human health assessment and an indication whether the active substance can be expected to meet the approval criteria which are applicable to human health as laid down in Article 4 of Regulation (EC) No 1107/2009.
Recital 9, Regulation (EU) 2020/17
In forcesince 10 Jan 2020cited 1×
Judgment of the General Court (Seventh Chamber, Extended Composition) of 4 October 2023. Ascenza Agro, SA and Industrias Afrasa, SA v EuropeDecision
The applicants submit that, contrary to what appears to be stated in recital 9 of the contested regulation, according to which new concerns for human health were raised during the expert discussion organised in April 2019 (see paragraph 24 …
4 Oct 2023 · 62020TJ0077